Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-A

- Actimab-A has received Orphan Drug Designation in the U.S. - Orphan Designation in the EU can result in regulatory assistance, reduced fees and 10 years of market exclusivity ...
December 12, 2016 07:00 ET | Source: Inspyr Therapeutics

Inspyr Announces Private Placement of $1.0 Million

WESTLAKE VILLAGE, Calif., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Inspyr Therapeutics (OTCQB:NSPX) (“Inspyr” or the “Company”), a biotech company developing novel prodrug therapeutics for the treatment of...
December 12, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AML

Patient focused webinar titled “Stem Cell Transplants for Acute Myeloid Leukemia: What you Need to Know” Webinar to be led by transplant expert, Dr. Patrick Stiff, Director of the Cardinal...
December 08, 2016 15:02 ET | Source: Wellist

Rock Health Selects Wellist for Diversity Leadership Award

BOSTON, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Wellist, a patient experience solutions provider, is among a select group of individuals and organizations receiving awards from Rock Health’s Top 50 in...
December 08, 2016 12:03 ET | Source: American Health Council

American Health Council Names Julie Hammon, MSN, RN, OCN to Nursing Board

NEW YORK, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Julie Hammon, Oncology Nurse Navigator at Oaklawn Hospital in Michigan, has been selected to join the Nursing Board at the American Health Council....
December 07, 2016 04:58 ET | Source: IASLC

Zusammenfassung der Forschungspräsentationen bei der 17. Welt-Lungenkrebs-Konferenz der Internationalen Vereinigung für das Studium von Lungenkrebs (International Association for the Study of Lung Cancer, IASLC) am Dienstag, dem 6. Dezember 2016

WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Die heutige Presseinformation zur 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) der IASLC setzte den Akzent auf aktive...
December 06, 2016 22:07 ET | Source: IASLC

Resumen de las presentaciones de investigación de la 17ª Conferencia Mundial sobre el Cáncer de Pulmón de la IASLC, martes 6 de diciembre de 2016

VIENA, AUSTRIA--(Marketwired - 6 de diciembre de 2016) - La rueda de prensa de hoy en la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en la prevención activa. Los...
December 06, 2016 20:06 ET | Source: IASLC

Résumé des présentations d'études de la 17e Conférence mondiale sur le cancer du poumon de l'IASLC (mardi 6 décembre 2016)

VIENNE, AUTRICHE--(Marketwired - 6 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur la...
December 06, 2016 18:33 ET | Source: IASLC

Resumo das Apresentações das Pesquisas na IASLC 17a Conferência Mundial sobre Câncer de Pulmão de terça-feira, dia 6 de dezembro de 2016

VIENNA, AUSTRIA--(Marketwired - 6 de dezembro de 2016) - A coletiva com a mídia de hoje na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC)...
December 06, 2016 16:05 ET | Source: Peregrine Pharmaceuticals Inc.

Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

TUSTIN, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...